It's all in the head
CCH Newsletter - Spring 2013
Children's Cancer Hospital takes team approach to brain, spinal cancers
The new Pediatric Brain Tumor Program of The University of Texas MD Anderson Children’s Cancer Hospital and Children’s Memorial Hermann Hospital brings together the strengths of two leading medical institutions to treat brain and spinal cancer in children and young adults.
Primary in these strengths is the excellence in comprehensive care that both hospitals bring to the program.
- Leading expertise — Children receive care by some of the nation’s top specialists in neuro-oncology, neuro-surgery, radiation oncology, neuro-pathology and other sub-specialties.
- Support services — Patients have access to a variety of services and programs to ensure their emotional and social well-being during treatment and into survivorship. An in-hospital school, child life specialists, vocational counselors, psychologists, developmental specialists and school re-entry coordinators are just a few of the services provided to help patients maintain a normal life during treatment.
- Multidisciplinary approach — Each patient’s case is discussed together by pediatric neuro-oncologists, neuro-surgeons, radiation oncologists and neuro-radiologists to ensure a unified approach to care.
- Family-centered care — Parents partner with staff in planning the best treatment approach for their child. In addition, multiple advisory councils involving parents, patients and staff provide integral feedback in the daily decision-making process of the hospital.
- Innovative treatment — MD Anderson’s Brainsuite®, proton therapy, gamma knife radiosurgery, stereotactic radiotherapy, clinical trials, translational brain tumor research, advanced imaging technology and minimally invasive endoscopic tumor resection are new and advanced ways used to treat pediatric brain tumors.
- Clinical trial — A clinical trial is offered solely through this collaborative program for recurrent medulloblastoma, ependymoma and atypical teratoid rhabdoid tumors that uses the direct infusion of chemotherapy into the fourth ventricle.